Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 5

RecBio delivers IPO

The China Resources and Legend Holdings-backed vaccine technology developer floated in Hong Kong in a $97.7m offering following nearly $460m in funding.

Apr 5, 2022

Daily Deal Round Up: March 29, 2022

DigitalBridge Ventures led wireless adoption software developer Celona's $60m series C round while Papaya is paying up to $200m for Rakuten-backed payment platform developer Azimo.

Mar 29, 2022

GoTo gets $1.1bn in initial public offering

The multicorporate-backed diversified mobile app operator has listed on IDX having priced its shares at near the top of their range.

Mar 29, 2022

AN2 Therapeutics prices $69m IPO

The Brii Biosciences-backed lung disease treatment developer priced an upsized offering in the middle of its range.

Mar 29, 2022

Hub Cyber Security organises $1.28bn reverse merger

The Axa-backed cybersecurity software provider is set to list through a tie-up with Mount Rainier Acquisition Corp.

Mar 25, 2022

Moi moves towards public listing

The KDDI and Sinar Mas-backed video streaming platform developer is scheduled to float on the Tokyo Stock Exchange’s Growth Market on April 27 at a valuation of approximately $51m.

Mar 24, 2022

Leapmotor looks to Hong Kong flotation possibilities

Dahua, Shanghai Electric and CRRC are set to exit the smart EV manufacturer, which is reportedly set to raise at least $1bn in the flotation.

Mar 18, 2022

GoTo targets $1.1bn in initial public offering

More than 20 corporate backers are due to score exits through an offering that could value the online consumer services portal at nearly $29bn.

Mar 15, 2022

FinAccel calls off $2.5bn reverse merger

Unfavourable market conditions have scuppered the corporate-backed consumer credit company’s planned reverse takeover as it opts instead for more private funding.

Mar 15, 2022

AN2 Therapeutics examines IPO possibilities

The Brii Biosciences-backed lung diease drug developer will use the proceeds from the offering to advance its epetraborole drug candidate and expand into Japan.

Mar 8, 2022
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here